India AI for Biotech Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the India AI for Biotech Market was valued at USD 115.0 million in 2025 and is projected to reach USD 212.94 million by 2032, growing at a CAGR of approximately 9.2% during 2026–2032.
India AI for Biotech Market Highlights
| Report Metric | Details |
| Report Name | India AI for Biotech Market |
| Market Size 2025 | USD 115.0 million |
| Market Size 2032 | USD 212.94 million |
| Absolute Growth 2025–2032 | USD 97.94 million |
| CAGR 2026–2032 | 9.2% |
| Peak Annual Growth | 11.8% in 2029 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Application Area, 2025 | Drug Discovery (39% share) |
| Leading Technology Type, 2025 | Machine Learning (43% share) |
| Leading Distribution Channel, 2025 | Biotech Cloud Platforms (45% share) |
| Leading End User, 2025 | Biopharmaceutical Companies (47% share) |
| Fastest-Growing Application Area | CRISPR Analysis (10.4% CAGR) |
| Fastest-Growing Technology Type | Deep Neural Networks (10.5% CAGR) |
| Fastest-Growing Distribution Channel | SaaS Licensing (10.2% CAGR) |
| Fastest-Growing End User | Genomics Firms (11.5% CAGR) |
| Growing Sector | Biopharmaceutical Companies |
| Key End Users | Biopharmaceutical Companies, Genetic Engineering Labs, Genomics Firms, Academic Biotech Research Centers |
India AI for Biotech Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
Below, each year's estimated growth is shown next to the factor that most influenced it.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 10.6 | The market experienced strong growth due to high demand from biopharmaceutical companies. |
| 2023 | 9.1 | Growth slowed as companies adjusted to new AI integration processes in biotech. |
| 2024 | 10.5 | Demand surged as more drug discovery projects adopted AI technologies. |
| 2025 | 7.8 | The market saw slower growth as regulatory approvals for new AI tools took longer. |
| 2026 | 11.6 | Growth is expected to accelerate with increased funding for AI-driven biotech innovations. |
| 2027 | 7.4 | A slowdown is projected as some projects face challenges in implementation. |
| 2028 | 10.7 | Demand is expected to rise again as AI applications in genetic engineering gain traction. |
| 2029 | 11.8 | The market is projected to peak with the highest growth rate as AI tools become essential in biotech. |
| 2030 | 7.2 | Growth is expected to slow due to regulatory delays in new AI product approvals. |
| 2031 | 6.8 | The market will continue to grow at a slower pace as competition intensifies. |
| 2032 | 9.0 | Demand is projected to rise again as new AI technologies emerge in biotech. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
India AI for Biotech Market Synopsis
AI for Biotech Market in India encompasses the application of artificial intelligence technologies in biotechnology, particularly for drug discovery and genetic analysis. These technologies are developed using advanced algorithms and machine learning techniques that accelerate drug development processes. The AI for Biotech Market is expanding due to rising demand from domestic biopharmaceutical companies and research institutions. Collaborations with international firms further drive this growth, stimulating investment and innovation in the sector.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Increasing adoption of AI in drug discovery processes | Driver | High | Drug Discovery |
| Growing investment in biotechnology research and development | Driver | High | Biopharmaceutical Companies |
| Rising demand for AI-driven solutions in healthcare | Opportunity | High | Genomics Firms |
| Expanding cloud infrastructure for biotech applications | Opportunity | Medium | Biotech Cloud Platforms |
| Regulatory hurdles in AI tool approvals | Restraint | High | AI Algorithms |
| Limited understanding of AI capabilities among some biotech firms | Restraint | Medium | Genetic Engineering Labs |
| High costs associated with AI technology implementation | Challenge | High | Academic Biotech Research Centers |
| Shortage of skilled professionals in AI and biotech fields | Challenge | Medium | Biopharmaceutical Companies |
Evaluation of Drivers in India AI for Biotech Market (2026–2032)
Below mentioned are some major drivers and their influence on market dynamics.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| High demand for faster drug development | Drug Discovery | AI-based tools are integrated into 60% of new biopharma projects, significantly reducing development timelines. |
| Increased funding for biotech innovations | Biopharmaceutical Companies | The Biotechnology Industry Research Assistance Council provides grants for AI-driven projects, boosting innovation. |
| Growing need for precise genetic analysis | CRISPR Analysis | AI improves the efficiency of CRISPR applications, leading to higher adoption rates in research. |
| Expansion of cloud services for biotech | Biotech Cloud Platforms | The Make in India initiative supports local production of AI-driven technologies, enhancing market access. |
| Rising focus on genomic research | Genomics Firms | The Indian Council of Medical Research supports AI in health-related biotech research, increasing demand. |
The AI for Biotech market in India is growing on the back of increasing demand for faster drug development, precise genetic analysis, and rising genomic research. AI-based drug discovery tools are integrated into 60% of new biopharma projects, which significantly reduces development timelines. Funding for AI-driven projects is boosted by the Biotechnology Industry Research Assistance Council, enhancing innovation in the sector. As a result, biopharmaceutical companies are investing more in AI applications, creating a competitive environment for suppliers.
Evaluation of Restraints in India AI for Biotech Market
The key brakes on demand, and where they bite hardest, are shown below.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| Regulatory hurdles in AI tool approvals | AI Algorithms | The Drug Controller General of India regulates approvals, causing delays in market entry that can extend up to two years. |
| Limited understanding of AI capabilities among some biotech firms | Genetic Engineering Labs | Many firms lack expertise in AI, hindering their ability to adopt these technologies effectively. |
| High costs associated with AI technology implementation | Academic Biotech Research Centers | Budget constraints limit the ability of research centers to invest in advanced AI tools, affecting research outcomes. |
| Shortage of skilled professionals in AI and biotech fields | Biopharmaceutical Companies | The talent gap affects the implementation of AI solutions in drug development, slowing project timelines. |
| Concerns over data privacy and security | Biotech Cloud Platforms | Regulations regarding data handling can slow down the adoption of cloud-based solutions, impacting deployment. |
India AI for Biotech Market Challenges
Producers in the India AI for Biotech market face high costs due to lengthy drug approval processes, which can delay product launches by up to 18 months. Buyers struggle with skills shortages in AI and biotechnology, limiting access to qualified professionals and resulting in project delays that can extend timelines by 30%. Many firms contend with outdated technology, as only 60% of new biopharma projects currently integrate AI-based tools, which reduces their competitive advantage. Regulatory hurdles complicate market entry, with the Drug Controller General of India imposing strict approval timelines that can stretch up to two years for new biotech products, impacting responsiveness for all stakeholders.
Trends in the India AI for Biotech Market
Below mentioned are some of the trends shaping the India AI for Biotech Market growth.
- Shift towards AI-driven Drug Discovery: In 2023, 60% of new biopharma projects integrated AI-based tools, reflecting a shift in drug development practices. This trend is expected to improve efficiency and reduce timelines for bringing new drugs to market.
- Increased Focus on Genomic Research: Genomics firms are prioritising AI applications, with an expected growth rate of 11.5% by 2032. This shift is driven by the need for precise data analysis in genomic studies, supported by funding from the Indian Council of Medical Research.
- Adoption of Biotech Cloud Platforms: The use of biotech cloud platforms is rising, with a 45% market share expected by 2025. This trend is driven by the Make in India initiative, which encourages local production of AI-driven technologies.
- Emergence of Deep Neural Networks: Deep neural networks are gaining traction in biotech, projected to grow at 10.5% from 2026 to 2032. Their effectiveness in complex pattern recognition is driving their adoption across various biotech applications.
Investment Opportunities in the India AI for Biotech Market
Investors looking at the India AI for Biotech Market should consider the following areas.
- Biopharmaceutical Companies Seeking AI Solutions: Biopharmaceutical companies are increasingly looking for AI-driven tools to improve drug development processes. With the Indian biopharmaceutical market expected to grow to $50 billion by 2025, there is a strong opportunity for investment in AI technologies.
- Partnerships with Research Institutions: Collaborating with academic biotech research centers presents a strong opportunity for AI technology providers. These partnerships can facilitate access to funding and expertise, particularly in innovative drug discovery projects.
- Expansion of AI in Genetic Engineering Labs: Genetic engineering labs are seeking advanced AI solutions to improve research outcomes. With funding from the Biotechnology Industry Research Assistance Council, suppliers can enter this market through targeted partnerships.
- Growth in SaaS Licensing Models: The SaaS licensing model is gaining popularity among biotech firms, projected to grow at 10.2% from 2026 to 2032. Suppliers can enter this space by offering tailored AI solutions for specific biotech applications.
Government Initiatives in the India AI for Biotech Market
The National Biotechnology Development Strategy 2021, established by the Department of Biotechnology, aims to boost AI integration in the sector. This strategy focuses on increasing research funding and innovation in AI applications, benefiting producers and buyers in biotechnology. By promoting collaboration between public and private entities, the strategy seeks to strengthen the overall biotechnology framework in India. The initiative is projected to increase the availability of AI-driven solutions, facilitating advancements in drug discovery and genetic analysis. Stakeholders are encouraged to invest in AI technologies to remain competitive in the evolving market.
The Atal Innovation Mission, launched by NITI Aayog in 2020, supports startups in the biotech sector, promoting AI applications in health and agriculture. This mission provides funding and resources to encourage innovation, allowing biotech companies to develop and implement AI-driven solutions. The Biotechnology Industry Research Assistance Council plays a key role by offering grants for AI-driven biotech projects, stimulating research and development. These initiatives enable buyers to access advanced technologies and improve their capabilities in drug development and genetic engineering. By creating a supportive environment for innovation, these schemes contribute to the growth of the AI for Biotech market in India.
Future Insight of the India AI for Biotech Market
The India AI for Biotech market will experience significant transformations by 2032, driven by advancements in AI technologies that accelerate drug development processes. The National Biotechnology Development Strategy 2021 will promote innovation and increase funding opportunities for biotech projects. Collaborations with international research institutions will facilitate knowledge exchange and technology transfer.
Market Segmentation Analysis
The report offers a comprehensive study of the following market segments and their leading categories in the market.
By Application Area – Drug Discovery Dominated, CRISPR Analysis Expected to Grow Fastest
According to Ravi Bhandari, Research Head at 6Wresearch, the largest application area category in 2025 was Drug Discovery, with a 39% share of total revenue. Drug discovery holds the largest market share in India as it is crucial for advancing biopharmaceutical projects, with over 60% of new initiatives integrating these tools. This high adoption is largely due to the pressing need for faster and more efficient drug development processes. Over 2026–2032, CRISPR Analysis is expected to post the fastest growth, at a CAGR of 10.4%. The CRISPR analysis segment is experiencing rapid growth, driven by its enhanced precision in gene editing applications, which attracts significant investments. The increasing focus on genetic engineering among numerous biotech firms further propels this segment's expansion. Suppliers should prioritise solutions for drug discovery to capture a substantial share of this growing market.
By Technology Type – Machine Learning Dominated, Deep Neural Networks Expected to Grow Fastest
Machine Learning took a 43% share of technology type in 2025, more than any other category. Machine learning is the leading technology type in the AI for biotech market, serving as a fundamental enabler for effective data analysis across various applications. Its widespread use in numerous biotech projects solidifies its dominant position in the market. Deep Neural Networks are set to record the highest CAGR in this split, 10.5% over 2026–2032. Deep neural networks are growing the fastest among technology types, mainly due to their ability to handle complex datasets and improve pattern recognition. This capability is attracting increased research funding and initiatives towards deep learning techniques. Buyers should focus on machine learning solutions that incorporate deep neural networks to stay competitive in the biotech industry.
By Distribution Channel – Biotech Cloud Platforms Dominated, SaaS Licensing Expected to Grow Fastest
Biotech Cloud Platforms accounted for a 45% market share by distribution channel in 2025. Biotech cloud platforms dominate the distribution channel segment, as they provide scalable and accessible environments for deploying AI solutions across the biotech industry. Their ability to support multiple users and projects simultaneously makes them indispensable for biotech firms. SaaS Licensing is projected to grow fastest, at a CAGR of 10.2% during 2026–2032. SaaS licensing is rapidly gaining traction as the fastest-growing distribution channel, driven by the demand for flexible and cost-effective access to AI technologies. This model allows firms to quickly adopt and implement AI solutions without heavy upfront investments. Suppliers must focus on developing SaaS-based offerings to meet the increasing demand for accessible AI solutions in the biotech sector.
By End User – Biopharmaceutical Companies Dominated, Genomics Firms Expected to Grow Fastest
Biopharmaceutical Companies held a 47% share of the India AI for Biotech Market by end user in 2025. Biopharmaceutical companies lead the end user segment, being the primary adopters of AI technologies for drug development and research. Their significant investments in these technologies highlight their reliance on AI to maintain a competitive edge in the market. The quickest growth will come from Genomics Firms, forecast to expand at a CAGR of 11.5% between 2026 and 2032. Genomics firms represent the fastest-growing end user group, leveraging AI to enhance genomic data analysis and interpretation. This growth is fuelled by the rising importance of genomic research in personalised medicine and healthcare. Buyers should explore partnerships with genomics firms to leverage AI advancements and improve their research capabilities.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- India AI for Biotech Market Outlook
- Market Size of India AI for Biotech Market, 2025
- Forecast of India AI for Biotech Market, 2032
- Historical Data and Forecast of India AI for Biotech Revenues & Volume for the Period 2022 - 2032F
- India AI for Biotech Market Trend Evolution
- India AI for Biotech Market Drivers and Challenges
- India AI for Biotech Price Trends
- India AI for Biotech Porter's Five Forces
- India AI for Biotech Industry Life Cycle
- Historical Data and Forecast of India AI for Biotech Market Revenues & Volume By Application Area for the Period 2022 - 2032F
- Historical Data and Forecast of India AI for Biotech Market Revenues & Volume By Drug Discovery for the Period 2022 - 2032F
- Historical Data and Forecast of India AI for Biotech Market Revenues & Volume By CRISPR Analysis for the Period 2022 - 2032F
- Historical Data and Forecast of India AI for Biotech Market Revenues & Volume By DNA Sequencing for the Period 2022 - 2032F
- Historical Data and Forecast of India AI for Biotech Market Revenues & Volume By Protein Structure Prediction for the Period 2022 - 2032F
- Historical Data and Forecast of India AI for Biotech Market Revenues & Volume By Technology Type for the Period 2022 - 2032F
- Historical Data and Forecast of India AI for Biotech Market Revenues & Volume By Machine Learning for the Period 2022 - 2032F
- Historical Data and Forecast of India AI for Biotech Market Revenues & Volume By AI Algorithms for the Period 2022 - 2032F
- Historical Data and Forecast of India AI for Biotech Market Revenues & Volume By Deep Neural Networks for the Period 2022 - 2032F
- Historical Data and Forecast of India AI for Biotech Market Revenues & Volume By Reinforcement Learning for the Period 2022 - 2032F
- Historical Data and Forecast of India AI for Biotech Market Revenues & Volume By Distribution Channel for the Period 2022 - 2032F
- Historical Data and Forecast of India AI for Biotech Market Revenues & Volume By Biotech Cloud Platforms for the Period 2022 - 2032F
- Historical Data and Forecast of India AI for Biotech Market Revenues & Volume By Specialized B2B Portals for the Period 2022 - 2032F
- Historical Data and Forecast of India AI for Biotech Market Revenues & Volume By SaaS Licensing for the Period 2022 - 2032F
- Historical Data and Forecast of India AI for Biotech Market Revenues & Volume By Direct Institutional Sales for the Period 2022 - 2032F
- Historical Data and Forecast of India AI for Biotech Market Revenues & Volume By End User for the Period 2022 - 2032F
- Historical Data and Forecast of India AI for Biotech Market Revenues & Volume By Biopharmaceutical Companies for the Period 2022 - 2032F
- Historical Data and Forecast of India AI for Biotech Market Revenues & Volume By Genetic Engineering Labs for the Period 2022 - 2032F
- Historical Data and Forecast of India AI for Biotech Market Revenues & Volume By Genomics Firms for the Period 2022 - 2032F
- Historical Data and Forecast of India AI for Biotech Market Revenues & Volume By Academic Biotech Research Centers for the Period 2022 - 2032F
- India AI for Biotech Import Export Trade Statistics
- Market Opportunity Assessment By Application Area
- Market Opportunity Assessment By Technology Type
- Market Opportunity Assessment By Distribution Channel
- Market Opportunity Assessment By End User
- India AI for Biotech Top Companies Market Share
- India AI for Biotech Competitive Benchmarking By Technical and Operational Parameters
- India AI for Biotech Company Profiles
- India AI for Biotech Key Strategic Recommendations
Market Covered
This report examines the market across the segments below.
By Application Area
- Drug Discovery
- CRISPR Analysis
- DNA Sequencing
- Protein Structure Prediction
By Technology Type
- Machine Learning
- AI Algorithms
- Deep Neural Networks
- Reinforcement Learning
By Distribution Channel
- Biotech Cloud Platforms
- Specialized B2B Portals
- SaaS Licensing
- Direct Institutional Sales
By End User
- Biopharmaceutical Companies
- Genetic Engineering Labs
- Genomics Firms
- Academic Biotech Research Centers
